PDS Biotechnology proposed offering

NetScientific plc

(“NetScientific” or the “Company”)

PDS Biotechnology proposed offering

London, UK – 11 February 2020:  NetScientific plc (AIM: NSCI), the transatlantic healthcare IP commercialisation group, announces that its portfolio company PDS Biotechnology Corporation (“PDS”) (Nasdaq:PDSB) today made a further announcement concerning its proposed offering to raise approximately US$12 million (c.£9.3 million).

PDS mentioned in today’s announcement that, in connection with NetScientific’s expression of interest to subscribe in its offering, upon consummation of the offering it will appoint a designee of NetScientific to its board of directors.

NetScientific is considering investing £0.5 million in the offering.

A further announcement will be made as soon as appropriate

#  #  #

For more information, please contact:

About NetScientific

NetScientific PLC is a transatlantic healthcare IP commercialisation Group focused on technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people.

For more information, please visit the website at www.NetScientific.net